Top Markets
#1 Siren Siren +35.01%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.42%
#3 Wiki Cat Wiki Cat +20.32%
#4 Ribbita by Virtuals Ribbita by Virtuals +19.56%
#5 Cysic Cysic +17.69%
#6 Velvet Velvet +17.23%
#7 KUB Coin KUB Coin +16.76%
#8 PulseChain PulseChain +16.52%
#9 BasedHype BasedHype +14.69%
#10 Bitway Bitway +14.04%
Coin of the day
Siren Siren
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
NeuroSense Therapeutics Ltd. NeuroSense Therapeutics Ltd.

NeuroSense Therapeutics Ltd.

NRSN
Classificação em ações #31074
NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical... NeuroSense Therapeutics Ltd. operates as a biotechnology firm in the clinical development phase, committed to discovering and developing effective therapies for individuals suffering from severe neurodegenerative conditions. The company's leading drug candidate, PrimeC, is an innovative oral formulation that has successfully concluded Phase IIa clinical investigations for the management of amyotrophic lateral sclerosis (ALS). Additionally, its early-stage research pipeline features StabiliC, a potential treatment for Parkinson's disease, and CogniC, which is under development for Alzheimer's disease. Established in 2017, NeuroSense Therapeutics Ltd. is headquartered in Herzliya, Israel.
Preço da ação
$0.404
Valor de mercado
$14.28M
Variação (1 dia)
-10.42%
Variação (1 ano)
-67.68%
País
IL
Negociar NeuroSense Therapeutics Ltd. (NRSN)

Categoria

Healthcare
EPS de NeuroSense Therapeutics Ltd. (NRSN)
EPS em 2026 TTM: 0
De acordo com os últimos relatórios financeiros e o preço das ações da NeuroSense Therapeutics Ltd., o EPS atual da empresa (TTM) é 0. No final de 2026, a empresa teve um EPS de 0, igual a ao EPS de 2026, que foi de 0.
Histórico de EPS da NeuroSense Therapeutics Ltd. de 2026 até 2026
EPS no final de cada ano
Ano EPS Alterar
Não há dados suficientes para as datas fornecidas.
EPS de empresas semelhantes ou concorrentes
Empresa EPS Diferença de EPS País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $2.98 -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE